Sandra L. Tunis - Concepedia

Author

Sandra L. Tunis

Also Known As

S L Tunis, S Tunis, S. L. Tunis, S. Tunis, S.L. Tunis, SANDRA L. TUNIS, SANDRA TUNIS, Sandra L Tunis, Sandra L. Tunis, Sandra Tunis

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)IQVIA (United States)University of California, San Francisco Health Outcomes Solutions (United States)Thomas Jefferson University

About

Sandra L. Tunis is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and health economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	381
2	Social Sciences	7	7	188
3	Public Health	6	6	174
4	Health Sciences	2	2	80
5	Education	1	1	32

Sandra L. Tunis

Publications

924

Citations

H-Index

Page 1

	Year	Citations
Reliability, Validity, and Application of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol Sandra L. Tunis, Thomas W. Croghan, Douglas K. Heilman, Medical Care	1999	95
Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines Prudence Z Lim, Sandra L. Tunis, William S. Edell, Bipolar Disorders	2001	67
Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United States Martha Bayliss, Regina Rendas‐Baum, Michelle K. White, Health and Quality of Life Outcomes	2012	62
Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting Elise M. Pelletier, Paula Smith, Kristina S. Boye, Applied Health Economics and Health Policy Diabetes ManagementHealth EconomicsHealth PolicyMedicineDiabetes	2008	59
Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial Sandra L. Tunis, Douglas E. Faries, Allen W. Nyhuis, Value in Health PsychiatryHealth EconomicsPsychotropic MedicationPsychotic Disorder1-Year Trial	2005	53
Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states. Sandra L. Tunis, Michael E. Minshall PubMed	2008	49
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia in Geropsychiatric Inpatients William S. Edell, Sandra L. Tunis American Journal of Geriatric Psychiatry Geriatric PsychiatryPsychopathologyAlzheimer's DiseasePsychiatryGeriatrics	2001	46
Comparison Between the Effects of Atypical and Traditional Antipsychotics on Work Status for Clients in a Psychiatric Rehabilitation Program Piper Meyer-Kalos, Gary R. Bond, Sandra L. Tunis, The Journal of Clinical Psychiatry	2002	40
Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia. Sandra L. Tunis, Bryan M. Johnstone, P. Joseph Gibson, PubMed Total CostPerceived HealthPsychiatric EvaluationPsychotropic MedicationPsychopharmacology	1999	39
Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada Meaghan E.St. Charles, Hamid Sadri, Michael E. Minshall, Clinical Therapeutics Diabetes ManagementHealth EconomicsHealth PolicyInsulin ManagementDiabetes	2009	37

Page 1